Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AGO Austria recommendations for genetic testing of patients with ovarian cancer.

Wiener klinische Wochenschrift - 1 Aug 2015

Marth Christian, Hubalek Michael, Petru Edgar, Polterauer Stephan, Reinthaller Alexander, Schauer Christian, Scholl-Firon Tonja, Singer Christian F, Zschocke Johannes, Zeimet Alain G

Abstract excerpt

In Austria, 700 women are diagnosed every year with ovarian carcinoma. Approximately 15% of the patients with epithelial ovarian cancer have a germline mutation in the BRCA1 or BRCA2 genes. The increased incidence of breast and/or ovarian cancer in genetically related family members has given rise to the term "hereditary breast and ovarian cancer syndrome" (HBOC). Some 25-55% of these in-family diseases are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Austria
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to BRCA2 Protein

Share to Early Detection of Cancer

Share to Medical Oncology

Share to Ovarian Neoplasms

Share to Practice Guidelines as Topic

Source

Open in PubMed Open full text

Identifiers

PMID: 26109557
DOI: 10.1007/s00508-015-0814-7
PMCID: PMC4536270

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AGO Austria recommendations for genetic testing of patients with ovarian cancer.PMID 26109557Read ↗

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.Semantic proximity Read ↗

EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.Semantic proximity Read ↗

[Recommended Extension of Indication Criteria for Genetic Testing of BRCA1 and BRCA2 Mutations in Hereditary Breast and Ovarian Cancer Syndrome].Semantic proximity Read ↗

Risk assessment & genetic testing.Semantic proximity Read ↗

Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome.Semantic proximity Read ↗

Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.Semantic proximity Read ↗

Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.Semantic proximity Read ↗

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.Semantic proximity Read ↗

NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian CancerSemantic proximity Read ↗

SEOM clinical guidelines in Hereditary Breast and ovarian cancer.Semantic proximity Read ↗

Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.